Chronic Bartonellosis treatment regimes and outcomes.

NIAID Data Ecosystem2026-03-09 收录

传染病治疗

临床疗效评估

数据链接：

https://figshare.com/articles/dataset/Chronic_Bartonellosis_treatment_regimes_and_outcomes_/4016427 数据链接链接失效反馈

官方服务：

资源简介：

Chronic Bartonellosis treatment regimes and outcomes.

创建时间：

2016-10-26

COR peak week 1 improvement and COR peak week 5 improvement.

抗抑郁药物疗效

临床疗效评估

Response and remission rates after 5 weeks of treatment in 40 depressed patients (sample 2) treated with either reboxetine (n = 20) or mirtazapine (n = 20) [33]. Patients are subdivided into COR peak

NIAID Data Ecosystem50

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

临床疗效评估

医疗质量指标

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

Figshare2022-11-02 更新30

Overall 24-week changes in clinical and laboratory parameters.

临床疗效评估

医疗参数追踪

Overall 24-week changes in clinical and laboratory parameters.

Figshare2015-12-02 更新20

Supplementary Material for: A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression

肿瘤免疫治疗

临床疗效评估

Introduction: In a multicenter, open-label, parallel-group, randomized, phase 2 study for pretreated advanced hepatocellular carcinoma (HCC), camrelizumab showed potent antitumor activity and acceptab

NIAID Data Ecosystem50

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

视网膜静脉阻塞

临床疗效评估

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

Figshare2018-09-20 更新20

Chronic Bartonellosis treatment regimes and outcomes.

资源简介：

相关数据集